Metabolic Disorders News

Studies show vitamin D may benefit cardiovascular, skin and metabolic disorders - News-Medical.net



CBC.ca
 
Studies show vitamin D may benefit cardiovascular, skin and metabolic disorders 
News-Medical.net
Vitamin D deficiency is common throughout the world and results in abnormalities of calcium, phosphorus and bone metabolism which can lead to muscle weakness, osteomalacia, osteopenia and osteoporosis. While some observational studies have shown that ...
Vitamin D non-skeletal health benefits unclear CBC.ca

all 5 news articles » 


CASiGEN Pharma gets GIBH world-wide license to bring new potential diabetes ... - pharmabiz.com



CASiGEN Pharma gets GIBH world-wide license to bring new potential diabetes ... 
pharmabiz.com
... USA and Asia, and the Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences (GIBH) have created CASiGEN Pharma Ltd. (CASiGEN) to bring new treatments for diabetes and other metabolic disorders to the global market.

and more » 


Timing of meals is tied to obesity - Boston Globe



CBC.ca
 
Timing of meals is tied to obesity 
Boston Globe
However, the mice with unrestricted eating times were more likely to become obese or have other metabolic disorders. The findings suggest that food may be better processed by the body when eating is restricted to confined hours of the day, ...
It's not just what you eat, it's when you eat WBAY

all 104 news articles » 


Hypoglycaemia related to inherited metabolic diseases in adults - 7thSpace Interactive (press release)



Hypoglycaemia related to inherited metabolic diseases in adults 
7thSpace Interactive (press release)
Nevertheless, some hypoglycaemic episodes remain unexplained, and inborn errors of metabolism (IEM) should be considered, particularly in cases of multisystemic involvement. In children, IEM are considered a differential diagnosis in cases of ...

 


80 healthcare professionals attend Metabolic Dieticians Workshop - Gulf Times



80 healthcare professionals attend Metabolic Dieticians Workshop 
Gulf Times
Out of nearly 160000 babies screened at Hamad Medical Corporation (HMC) for metabolic disorders in the last nine years, about 270 babies have tested positive, a leading neonatal expert said. Professor George Hoffmann, chairman of paediatrics at ...

 


Planning statistics show surge in unhealthy eating - Minivan News



Minivan News
 
Planning statistics show surge in unhealthy eating 
Minivan News
Health experts in the country have blamed the unhealthy diet of Maldivians for the high prevalence of cardiovascular diseases and metabolic disorders such diabetes among Maldivians, which account for almost 50 percent of the all deaths in the country.

 


miRagen Therapeutics Announces the Publication of Compelling Data Suggesting ... - MarketWatch (press release)



miRagen Therapeutics Announces the Publication of Compelling Data Suggesting ... 
MarketWatch (press release)
The data suggests that miRagen's lead program, MIRG-9103 (antimiR-208), in addition to providing benefit in the setting of cardiac dysfunction, may have therapeutic utility in a variety of metabolic disorders that contribute to Metabolic Syndrome.

and more » 


CASiGEN Pharma Receives A World-wide Exclusive License From GIBH To Bring New ... - MarketWatch (press release)



CASiGEN Pharma Receives A World-wide Exclusive License From GIBH To Bring New ... 
MarketWatch (press release)
... and the Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences (GIBH) today announced the creation of CASiGEN Pharma Ltd. (CASiGEN) to bring new treatments for diabetes and other metabolic disorders to the global market.

and more » 


Promethera Biosciences Treats First Patients With Promethera HepaStem - Laboratory Network



Promethera Biosciences Treats First Patients With Promethera HepaStem 
Laboratory Network
Biosciences, a Belgian biotechnology company developing Promethera HepaStem, a cell-based therapy for the treatment of liver-based metabolic diseases including Crigler-Najjar Syndrome and Urea Cycle Disorders, recently announces it has treated its ...

and more » 


Phase 3 Data Show NUCYNTAź ER (tapentadol) Extended-Release Tablets Provide ... - MarketWatch (press release)



Phase 3 Data Show NUCYNTAź ER (tapentadol) Extended-Release Tablets Provide ... 
MarketWatch (press release)
... can be challenging," said Aaron I. Vinik, MD, Ph.D., FCP, MACP, Director of Research and Neuroendocrine Unit at Strelitz Diabetes Center for Endocrine and Metabolic Disorders at Eastern Virginia Medical School, and lead investigator of the study.

and more »